Proxima Fusion bets €140M on a critical fusion ingredient dominated by Asian suppliers

Proxima Fusion’s €140 million bet on HTS tape production is less about the hardware itself and more about the geopolitics of fusion energy. High-temperature superconducting tape is one of the most constrained inputs in advanced fusion designs — it determines magnetic field strength, reactor size, and ultimately commercial viability. With Asian suppliers holding the lion’s share of production, any Western fusion startup is effectively exposed to a single point of failure. Proxima’s decision to build its own factory is a clear acknowledgment that fusion’s bottleneck isn’t physics; it’s manufacturing. This is a familiar pattern in clean tech. Solar, batteries, and now fusion are all learning the same lesson: breakthrough technologies don’t scale if the supply chain is controlled by a handful of overseas players. The Inflation Reduction Act and similar European initiatives have pushed for domestic manufacturing, but Proxima is moving ahead of policy, treating HTS tape as a strategic asset rather than a commodity. That’s a sharp instinct — but it also raises questions about capital allocation. €140 million is a meaningful chunk of a startup’s war chest, and it’s being spent on a factory instead of reactor physics. Still, the logic holds. If Proxima’s reactor design genuinely depends on HTS tape, then waiting for the market to catch up is not an option. The startup is essentially making a vertical integration play, similar to what Tesla did with batteries and what SpaceX did with engines. Whether that strategy pays off depends on execution: HTS tape production is notoriously difficult, with tight tolerances and demanding quality control. But if Proxima can pull it off, it will have a durable moat that competitors relying on third-party suppliers won’t easily cross. The bigger story here is the reshaping of fusion’s industrial base. For years, the narrative was about scientific milestones — net energy gain, plasma stability, and so on. Now the conversation is shifting to supply chains, factory floors, and strategic autonomy. That’s a sign the industry is maturing. Proxima’s move may be a hedge, but it’s also a signal that fusion companies are starting to think like manufacturers, not just research labs. Source: https://techcrunch.com/2026/09/10/proxima-fusion-bets-e140m-on-a-critical-fusion-ingredient-dominated-by-asian-suppliers/